51.38
Precedente Chiudi:
$51.32
Aprire:
$51.07
Volume 24 ore:
487.06K
Relative Volume:
0.70
Capitalizzazione di mercato:
$2.43B
Reddito:
$1.10B
Utile/perdita netta:
$186.50M
Rapporto P/E:
13.59
EPS:
3.7817
Flusso di cassa netto:
$267.19M
1 W Prestazione:
-6.33%
1M Prestazione:
+8.88%
6M Prestazione:
-23.07%
1 anno Prestazione:
-20.46%
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Nome
Prestige Consumer Healthcare Inc
Settore
Telefono
(914) 524-6800
Indirizzo
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PBH
Prestige Consumer Healthcare Inc
|
51.38 | 2.48B | 1.10B | 186.50M | 267.19M | 3.7817 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Aggiornamento | Sidoti | Neutral → Buy |
| 2024-12-09 | Downgrade | Sidoti | Buy → Neutral |
| 2024-06-21 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2022-11-17 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-05-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-06-29 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-04-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-04-07 | Ripresa | Sidoti | Neutral |
| 2020-03-26 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-24 | Iniziato | Oppenheimer | Perform |
| 2020-03-19 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2019-01-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Aggiornamento | Jefferies | Underperform → Hold |
| 2017-05-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Reiterato | B. Riley & Co. | Buy |
| 2016-11-17 | Iniziato | Gabelli & Co | Buy |
| 2016-08-12 | Aggiornamento | Sidoti | Neutral → Buy |
| 2016-03-08 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Iniziato | Piper Jaffray | Overweight |
| 2015-11-30 | Downgrade | Jefferies | Hold → Underperform |
| 2014-04-28 | Reiterato | B. Riley & Co. | Buy |
| 2014-04-28 | Reiterato | Oppenheimer | Outperform |
| 2013-07-09 | Iniziato | B. Riley & Co. | Buy |
Mostra tutto
Prestige Consumer Healthcare Inc Borsa (PBH) Ultime notizie
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Prestige Consumer Healthcare's Jeffrey Zerillo to Retire as SVP, Operations - TradingView
Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover? - Yahoo Finance
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript - AOL.com
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build - Investing.com
Prestige Consumer Healthcare (NYSE:PBH) Upgraded by Zacks Research to "Hold" Rating - marketbeat.com
Understanding Momentum Shifts in (PBH) - Stock Traders Daily
PBH: Deals Increase Sales Base by More than 20% - Smartkarma
Renaissance Technologies LLC Has $2.17 Million Stake in Prestige Consumer Healthcare Inc. $PBH - marketbeat.com
Quantinno Capital Management LP Acquires 19,281 Shares of Prestige Consumer Healthcare Inc. $PBH - marketbeat.com
Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference - The Manila Times
Prestige Consumer Executives Set for Aug. 12 Fireside Chat - Stock Titan
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo! Finance Canada
Prestige Consumer Healthcare (PBH): Analyst Ratings and Growth Potential Offer 23% Upside for Investors - DirectorsTalk Interviews
Prestige Consumer Healthcare (PBH) Is Up 5.6% After Raising Fiscal 2027 Outlook on Acquisitions - Sahm
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein - The National Law Review
Prestige Consumer Healthcare In (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Prestige Consumer Healthcare Q1 Earnings Call Highlights - Yahoo Finance
Prestige Consumer Healthcare (NYSE:PBH) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Prestige Consumer Healthcare (PBH) Stock Faces Margin Questions Despite Record Cash Flow - webull.com
Prestige Consumer Healthcare (PBH) Is Up 9.2% After Raising 2027 Outlook On Recent Acquisitions - Yahoo Finance
Prestige Consumer Healthcare Inc. $PBH Shares Bought by First Trust Advisors LP - marketbeat.com
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72 - Moomoo
Prestige Consumer Healthcare Inc (PBH) Stock News Today - TradingKey
PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised - cnhinews.com
Prestige Consumer Healthcare Stock (PBH) Opinions on Recent Earnings and M&A Activity - Quiver Quantitative
Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH) - The Globe and Mail
Prestige Consumer Healthcare Lifts Outlook on Acquisition-Driven Growth - The Globe and Mail
Prestige Consumer Healthcare Inc (PBH) (Q1 2027) Earnings Call H - GuruFocus
Earnings call transcript: Prestige Consumer beats Q1 2026 estimates as stock edges higher - Investing.com
Prestige Consumer Healthcare Inc (PBH) (Q1 2027) Earnings Call Highlights: Record Cash Flow and ... - Yahoo! Finance Canada
PBH Looks 23.2% Undervalued on GF Value™ - GuruFocus
Prestige Consumer Healthcare Inc. 2027 Q1ResultsEarnings Call Presentation (NYSE:PBH) 2026-08-06 - Seeking Alpha
Prestige Consumer Healthcare Shares Rise After Fiscal Q1 Beat, Fiscal 2027 Outlook Lifted - marketscreener.com
Is Prestige Consumer Healthcare Inc (PBH) Undervalued at 23.2% A - GuruFocus
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Prestige Consumer Healthcare (NYSE:PBH) Releases FY 2027 Earnings Guidance - MarketBeat
Prestige Consumer Healthcare Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Prestige Consumer Healthcare Inc. Raises Earnings Guidance for the Fiscal 2027 - marketscreener.com
PRESTIGENSUMER HEALTHCARE ($PBH) Releases Q1 2027 Earnings - Moomoo
Prestige Consumer Healthcare Inc. 2026: Revenue $265.71M, EPS $0.61— 10-Q Summary - TradingView
Prestige Consumer Healthcare (NYSE: PBH) expands with $1,045.0M wellness deal - Stock Titan
Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Reports Q1 Revenue $265.7M, vs. FactSet Est of $250.3M - marketscreener.com
Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot - marketscreener.com
Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Posts Q1 Adjusted EPS $0.98 per Share, vs. FactSet Est of $0.88 - marketscreener.com
Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results - The Manila Times
Prestige Consumer Healthcare公布2027财年第一季度业绩,基于Breathe Right和LaCorium的收购上调全年业绩预期 - moomoo.com
Prestige Consumer Healthcare beats Q1 revenue estimates, raises 2027 outlook - TradingView
Prestige Consumer Healthcare Inc Azioni (PBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):